Skip Navigation

Cardiovascular Research 1999 43(4):879-883; doi:10.1016/S0008-6363(99)00143-1
© 1999 by European Society of Cardiology
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Anvari, A.
Right arrow Articles by Gottsauner-Wolf, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Anvari, A.
Right arrow Articles by Gottsauner-Wolf, M.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Copyright © 1999, European Society of Cardiology

Angiotensin-converting enzyme and angiotensin II receptor 1 polymorphism in coronary disease and malignant ventricular arrhythmias

Anahit Anvaria,*, Zeynep Türela, Alice Schmidtb, Nilgün Yilmazb, Gert Mayerb, Kurt Hubera, E. Schusterc and Michael Gottsauner-Wolfa

aDepartment of Cardiology, University of Vienna, Vienna, Austria
bDepartment of Nephrology, University of Vienna, Vienna, Austria
cDepartment of Computer Sciences, University of Vienna, Vienna, Austria

* Corresponding author. Corresponding address: University of Vienna, Department of Cardiology, Währinger Görtel 18-20, A-1090 Vienna, Austria. Tel.: +43-40-400-4614, ext. 4965; fax: +43-408-1148 AAnvari{at}mail.kard.akh-wien.ac.at

Objectives: It has been reported that patients carrying the angiotensin-converting enzyme (ACE) deletion DD genotype with the angiotensin II type 1 (AT1) C allele are at increased risk for myocardial infarction. The frequency distribution of the ACE and AT1 receptor gene polymorphism and their possible relation regarding malignant ventricular arrhythmias in patients with coronary artery disease (CAD) and left ventricular dysfunction was determined. Methods: The ACE I/D and AT1 A/C polymorphisms (using polymerase chain reaction) in 100 Caucasian patients suffering from CAD with a history of malignant ventricular arrhythmias treated with an implantable cardioverter defibrillator (ICD group) was compared to 127 age-matched Caucasian patients with CAD and no history of malignant ventricular arrhythmias (control group). All patients had reduced left ventricular ejection fraction of <40% and were comparable regarding sex distribution, body mass index, ACE-inhibitor treatment, lipid status and duration of CAD. Results: The prevalence of DD/CC in the ICD group was significantly higher (19% versus 10%, p<0.0001). The risk for malignant ventricular arrhythmias was associated with the combination of ACE D and AT1 C alleles (odds-ratio: 2.4, 95% confidence interval 1.41 to 3.94, p<0.001). The distribution of ACE and AT1 genotypes was not different between the two group. Conclusions: Patients with coronary artery disease and left ventricular dysfunction carrying ACE D and AT1 C alleles are at increased risk for development of malignant ventricular arrhythmias. Because of available pharmacological inhibitors, these results may have clinical implications for the prevention of sudden cardiac death.

KEYWORDS Arrhythmia; Coronary disease; Renin angiotensin system; Angiotensin; Receptor-polymorphism


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
B. Ozben, I. Altun, V. Sabri Hancer, A. K. Bilge, A. M. Tanrikulu, R. Diz-Kucukkaya, A. S. Fak, E. Yilmaz, and K. Adalet
Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk?
Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 215 - 220.
[Abstract] [PDF]


Home page
Journal of Renin-Angiotensin-Aldosterone SystemHome page
C. Sekuri, F S. Cam, E. Ercan, I. Tengiz, A. Sagcan, E. Eser, A. Berdeli, and M. Akin
Renin-angiotensin system gene polymorphisms and premature coronary heart disease
Journal of Renin-Angiotensin-Aldosterone System, March 1, 2005; 6(1): 38 - 42.
[Abstract] [PDF]


Home page
Circ. Res.Home page
G. F. Tomaselli and D. P. Zipes
What Causes Sudden Death in Heart Failure?
Circ. Res., October 15, 2004; 95(8): 754 - 763.
[Abstract] [Full Text] [PDF]


Home page
StrokeHome page
P. Apfalter, M. R. Hammerschlag, J. Boman, J. Wojta, K. Huber, and I. Huk
Reliability of Nested PCR for the Detection of Chlamydia pneumoniae in Carotid Artery Atherosclerosis
Stroke, July 1, 2003; 34 (7): e73 - e75.
[Full Text] [PDF]


Home page
EuropaceHome page
M. Firouzi and W. A. Groenewegen
Gene polymorphisms and cardiac arrhythmias
Europace, January 1, 2003; 5(3): 235 - 242.
[Full Text] [PDF]


Home page
J Am Coll CardiolHome page
M. E. Khalil, A. W. Basher, E. J. Brown Jr, and I. A. Alhaddad
A remarkable medical story: benefits of angiotensin-converting enzyme inhibitors in cardiac patients
J. Am. Coll. Cardiol., June 1, 2001; 37(7): 1757 - 1764.
[Abstract] [Full Text] [PDF]


Home page
Eur Heart JHome page
A Jeron, C Hengstenberg, S Engel, H Lowel, G.A.J Riegger, H Schunkert, and S Holmer
The D-allele of the ACE polymorphism is related to increased QT dispersion in 609 patients after myocardial infarction
Eur. Heart J., April 2, 2001; 22(8): 663 - 668.
[Abstract] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.